{
    "clinical_study": {
        "@rank": "152962", 
        "arm_group": {
            "arm_group_label": "internet-delivered cognitive behavior therapy", 
            "arm_group_type": "Experimental", 
            "description": "Participants will be assigned to a 12 weeks internet-delivered cognitive behavior therapy program including therapist contact via an internet platform and telephone."
        }, 
        "brief_summary": {
            "textblock": "The main goal of this trial is to study the feasibility and effectiveness of\n      internet-delivered cognitive behavior therapy for adolescents with obsessive-compulsive\n      disorder."
        }, 
        "brief_title": "Internet-delivered CBT for Adolescents With Obsessive-Compulsive Disorder - a Pilot Study", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Obsessive-Compulsive Disorder", 
        "condition_browse": {
            "mesh_term": [
                "Obsessive-Compulsive Disorder", 
                "Compulsive Personality Disorder"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  a primary diagnosis of OCD as defined by DSM-IV TR\n\n          -  a total score of above 15 on the CY-BOCS\n\n          -  age between 12 and 17 years\n\n          -  ability to read and write Swedish\n\n          -  daily access to the internet\n\n          -  a parent that is able to co-participate in the treatment\n\n          -  Participants on psychotropic medication must have been on a stable dose for the last\n             6 weeks prior to baseline assessment\n\n          -  signed informed consent\n\n        Exclusion Criteria:\n\n          -  diagnosed autism spectrum disorder, psychosis or bipolar disorder\n\n          -  suicidal ideation\n\n          -  ongoing substance dependence\n\n          -  subject not able to read or understand the basics of the ICBT self-help material\n\n          -  completed CBT for OCD within last 12 months (defined as at least 5 sessions CBT\n             including exposure and response prevention)\n\n          -  ongoing psychological treatment for OCD or another anxiety disorder"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "17 Years", 
            "minimum_age": "12 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01809990", 
            "org_study_id": "BIPOCD1"
        }, 
        "intervention": {
            "arm_group_label": "internet-delivered cognitive behavior therapy", 
            "intervention_name": "Internet-delivered Cognitive Behavior Therapy", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "cognitive behavior therapy", 
            "pediatric obsessive-compulsive disorder", 
            "internet-delivered cognitive behavior therapy"
        ], 
        "lastchanged_date": "November 18, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Stockholm", 
                    "country": "Sweden"
                }, 
                "name": "Karolinska insititute"
            }
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "1", 
        "official_title": "Internet-delivered Cognitive Behavior Therapy for Adolescents With Obsessive-Compulsive Disorder - a Pilot Study", 
        "other_outcome": [
            {
                "description": "Patient Health Questionnaire PHQ-9 (Kroenke, Spitzer, & Williams, 2001) is a brief self-report measure of depressive symptoms in adults. PHQ-9 will be used to measure parental depressive symptoms.", 
                "measure": "Patient Health Questionnaire PHQ-9", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended"
            }, 
            {
                "description": "GAD-7 (Spitzer, Kroenke, Williams, & L\u00f6we, 2006) is a brief self-report measure of symptoms of general anxiety in adults. GAD-7 will be used to measure symptoms of anxiety in the parents.", 
                "measure": "GAD-7", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended"
            }, 
            {
                "description": "Obsessive Compulsive Inventory - Revised (OCI-R, Foa et al., 2002) is a reliable and valid 18-item self-report scale for screening of OCD in adults and will be used to measure parental OC symptoms of both parents.", 
                "measure": "Obsessive Compulsive Inventory - Revised", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended"
            }, 
            {
                "description": "Family Accommodation Scale, Parent-Report (FAS-PR, Flessner et al., 2009). The parent-report version of the FAS consists of 12 items focusing on accommodation behaviors of parents with a child with OCD.", 
                "measure": "Family Accommodation Scale, Parent-Report", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended"
            }
        ], 
        "overall_official": {
            "affiliation": "Karolinska Institutet", 
            "last_name": "Eva Serlachius, PhD, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Sweden: The National Board of Health and Welfare", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Change from Baseline of obsessions and compulsions after 12 weeks and at 3- and 6 months after treatment.", 
            "measure": "Children's Yale Brown Obsessive Compulsive Scale, CY-BOCS", 
            "safety_issue": "No", 
            "time_frame": "Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended"
        }, 
        "reference": [
            {
                "PMID": "12501574", 
                "citation": "Foa EB, Huppert JD, Leiberg S, Langner R, Kichic R, Hajcak G, Salkovskis PM. The Obsessive-Compulsive Inventory: development and validation of a short version. Psychol Assess. 2002 Dec;14(4):485-96."
            }, 
            {
                "PMID": "9255702", 
                "citation": "Goodman R. The Strengths and Difficulties Questionnaire: a research note. J Child Psychol Psychiatry. 1997 Jul;38(5):581-6."
            }, 
            {
                "PMID": "11556941", 
                "citation": "Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13."
            }, 
            {
                "PMID": "9183141", 
                "citation": "Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK, Cicchetti D, Leckman JF. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997 Jun;36(6):844-52."
            }, 
            {
                "PMID": "12550826", 
                "citation": "Shafran R, Frampton I, Heyman I, Reynolds M, Teachman B, Rachman S. The preliminary development of a new self-report measure for OCD in young people. J Adolesc. 2003 Feb;26(1):137-42."
            }, 
            {
                "PMID": "9648330", 
                "citation": "Spence SH. A measure of anxiety symptoms among children. Behav Res Ther. 1998 May;36(5):545-66."
            }, 
            {
                "PMID": "16717171", 
                "citation": "Spitzer RL, Kroenke K, Williams JB, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01809990"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Karolinska Institutet", 
            "investigator_full_name": "Eva Serlachius", 
            "investigator_title": "PhD", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Spence Child Anxiety Scale - Child and Parent version (SCAS/P, Spence, 1998) will be used as a child and parent self-report measure of anxiety related psychopathology.", 
                "measure": "Spence Child Anxiety Scale - Child and Parent version", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended"
            }, 
            {
                "description": "Symptom severity of depression in the adolescent will be assessed with Child Depression Inventory (CDI, Kovacs, 1985).", 
                "measure": "Child Depression Inventory", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended"
            }, 
            {
                "description": "Strengths Difficulties Questionnaire (SDQ, Goodman, 1997) is a widely used self- and parent-report behavioral screening questionnaire with six subscales: emotional problems, conduct problems, hyperactivity-inattention, peer problems, prosocial behavior", 
                "measure": "Strengths Difficulties Questionnaire", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended"
            }, 
            {
                "description": "The Children's Obsessional Compulsive Inventory Revised, (CHOCI-R, Shafran et al., 2003) is a self- and parent-report measure of pediatric OCD symptom severity.", 
                "measure": "Children's Obsessional Compulsive Inventory Revised", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended"
            }, 
            {
                "description": "Child Obsessive-Compulsive Impact Scale - Revised (COIS-R, Piacentini, Peris, Bergman, Chang, & Jaffer, 2007) is a self- and parent-report scale of OCD symptom impact on everyday life.", 
                "measure": "Child Obsessive-Compulsive Impact Scale - Revised", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended"
            }
        ], 
        "source": "Karolinska Institutet", 
        "sponsors": {
            "collaborator": {
                "agency": "Stockholm County Council, Sweden", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Eva Serlachius", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}